Advertisement
Advertisement
U.S. Markets close in 1 hr 19 mins
Advertisement
Advertisement
Advertisement
Advertisement

Alaunos Therapeutics, Inc. (TCRT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.6647-0.2073 (-23.77%)
As of 02:41PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/29/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.35
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.0100
52 Week Low 30.4100
50-Day Moving Average 31.3430
200-Day Moving Average 31.1843

Share Statistics

Avg Vol (3 month) 33.5M
Avg Vol (10 day) 31.21M
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 8171.72M
% Held by Insiders 110.01%
% Held by Institutions 136.33%
Shares Short (Oct 13, 2022) 429.39M
Short Ratio (Oct 13, 2022) 44.7
Short % of Float (Oct 13, 2022) 415.90%
Short % of Shares Outstanding (Oct 13, 2022) 413.59%
Shares Short (prior month Sep 14, 2022) 428M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,829.15%

Management Effectiveness

Return on Assets (ttm)-35.32%
Return on Equity (ttm)-84.46%

Income Statement

Revenue (ttm)398k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-49.24M
EBITDA -48.31M
Net Income Avi to Common (ttm)-54.25M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)60.01M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)27.52M
Total Debt/Equity (mrq)68.50
Current Ratio (mrq)2.29
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-40.66M
Levered Free Cash Flow (ttm)-20.27M
Advertisement
Advertisement